Maven Securities LTD Cytokinetics Inc Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $1.72 Million - $2.32 Million	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $927,000 - $1.79 Million	50,000 New	50,000 $1.79 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $1.14 Million - $1.55 Million	-57,441 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $407,444 - $563,444	21,941 Added 61.81%	57,441 $1.33 Million
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $68,670 - $128,745	-4,500 Reduced 11.25%	35,500 $738,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $823,199 - $1.16 Million	40,000 New	40,000 $882,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.77B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.